Key result
Larger hip circumference is linked to better HDL-cholesterol response following statin therapy in hypertensive patients.
Why the study?
The relationship between anthropometric measurements of body fat distribution and lipid response to statins in hypercholesterolemic hypertensive patients was investigated.
Is hip circumference associated with HDL-cholesterol response following statin therapy in hypercholesterolemic hypertensive patients?
Cohort (n=129)
Is hip circumference associated with HDL-cholesterol response following statin therapy in hypercholesterolemic hypertensive patients?
Hip circumference, a marker of peripheral adiposity, is positively associated with HDL-cholesterol increases following statin therapy in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Hip circumference was associated with greater HDL response to statins in hypertensives; hypothesis-generating and requires prospective validation.
AIM: This report investigated the relationship between anthropometric measurements of body fat distribution and lipid response to statins in hypercholesterolemic hypertensive patients. METHODS: We prospectively examined 129 subjects who used either simvastatin 20 mg/day (no.=83) or atorvastatin 10 mg/day (no.=46) for 3 months. Anthropometry included evaluation of body mass index, waist and hip circumferences, and waist-to-hip-ratio. RESULTS: Significant decreases in LDL (p<0.001), total cholesterol (p<0.001), and triglycerides (p=0.04) levels were detected after 3 months of therapy in the whole sample. At baseline, only an inverse correlation between waist circumference and HDLcholesterol levels was detected (r=-0.18; p=0.04). Conversely, a direct relationship between hip circumference and HDLcholesterol response to statins was found in the whole sample (r=0.24; p=0.006), while no other anthropometric measurement displayed significant correlation with lipid changes. The association between HDL-cholesterol response and hip circumference was further confirmed by stepwise regression analysis adjusted for baseline HDL-cholesterol levels, metabolic syndrome, body mass index, and waist circumference. CONCLUSIONS: Hip circumference, a surrogate marker of peripheral adiposity, is associated with HDL-cholesterol changes following statin therapy in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Pio-Magalhães et al. (2011) conducted a cohort in Hypercholesterolemic hypertensive patients (n=129). Hip circumference was evaluated on HDL-cholesterol response to statins (r=0.24, p=0.006). Hip circumference was directly associated with HDL-cholesterol response following 3 months of statin therapy in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: